Business Description
Nascent Pharma Holdings Inc
NAICS : 325411
SIC : 2833
ISIN : US63108T1051
Description
Nascent Pharma Holdings Inc has acquired a Subsidiary engaged in enforcing and commercializing the patents held by Nascent. The acquired patents cover liquid formulations of cannabis. The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis. Patented uses include using the liquid formulations to alleviate numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 16.86 | |||||
9-Day RSI | 28.19 | |||||
14-Day RSI | 35.36 | |||||
3-1 Month Momentum % | 24.17 | |||||
6-1 Month Momentum % | -6.88 | |||||
12-1 Month Momentum % | -0.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | 23.81 | |||||
OCF Margin % | 23.81 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 0.64 |
GF Valueâ„¢
Nascent Pharma Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nascent Pharma Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.066667:1 Stock Split | 2022-02-14 | 8.10 (+5.88%) | ||
| 0.003333:1 Stock Split | 2020-03-06 | 34.20 (-15.56%) | ||
| 0.1:1 Stock Split | 2013-06-04 | 688.57 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:NASC
No articles.
Press Release
Articles on Nascent Pharma Holdings Inc
No articles.